IE39102B1 - Method for the preparation of piperazine derivatives - Google Patents

Method for the preparation of piperazine derivatives

Info

Publication number
IE39102B1
IE39102B1 IE00650/74A IE65074A IE39102B1 IE 39102 B1 IE39102 B1 IE 39102B1 IE 00650/74 A IE00650/74 A IE 00650/74A IE 65074 A IE65074 A IE 65074A IE 39102 B1 IE39102 B1 IE 39102B1
Authority
IE
Ireland
Prior art keywords
ethyl
piperazinyl
oxo
dihydro
pyrimidine
Prior art date
Application number
IE00650/74A
Other versions
IE39102L (en
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3845373A external-priority patent/JPS5546400B2/ja
Priority claimed from JP5654473A external-priority patent/JPS565753B2/ja
Priority claimed from JP6446473A external-priority patent/JPS565755B2/ja
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of IE39102L publication Critical patent/IE39102L/en
Publication of IE39102B1 publication Critical patent/IE39102B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A process for preparing 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-c arboxylic acids(I) and its pharmaceutically acceptable salts, which comprises hydrolyzing 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-c arbonitrils(II') oxidizing 6-lower alkanoyl-8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrim idines (II"), and if desired, hydrolyzing the product; or subjecting alkyl 4-(N-substituted ethyl-N-ethyl)amino 2-(1-piperazinyl)-pyrimidine-5-carboxylates(IV) to a Dieckmann reaction, dehydrogenating the resulting 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6,7,8-tetrahydropyrido(2,3-d) pyrimidines (III), then oxidizing or hydrolyzing the resulting 5,8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxo-pyrido(2,3-d)pyrimidines(II) and if desired, converting the resulting 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido2,3-d) pyrimidine-6-carboxylic acids(II) to a pharmaceutically acceptable salt, and a process for proparing 5,8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxopyrido(2,3-d)pyrimidines(II), which comprises dehydrogenating 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6.7.8-tetrahydropyrido(2,3-d)pyrimid ines (III), or subjecting alkyl 4-(N-substituted ethyl-N-ethyl)amino-2-(1-piperazinyl)-pyrimidine-5-carboxylates(IV) to a Dieckmann reaction, and dehydrogenating the resulting 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6,7,8-tetrahydropyrido(2,3-d)pyrimid ines(III). The 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl) pyrido(2,3-d)pyrimidine-6-carboxylic acids (I) and their pharmaceutically acceptable salts are useful as antibacterial agents, and 5 8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxopyrido(2,3-c)pyrimidines (II) are used as intermediates for producing the 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl) pyrido(2,3-d)pyrimidine-6-carboxylic acids (I). A process for preparing 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids(I) and its pharmaceutically acceptable salts, which comprises hydrolyzing 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carbonitrils(II') oxidizing 6-lower alkanoyl-8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidines (II"), and if desired, hydrolyzing the product; or subjecting alkyl 4-(N-substituted ethyl-N-ethyl)amino 2-(1-piperazinyl)-pyrimidine-5-carboxylates(IV) to a Dieckmann reaction, dehydrogenating the resulting 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6,7,8-tetrahydropyrido(2,3-d) pyrimidines (III), then oxidizing or hydrolyzing the resulting 5,8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxo-pyrido(2,3-d)pyrimidines(II) and if desired, converting the resulting 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido¢2,3-d) pyrimidine-6-carboxylic acids(II) to a pharmaceutically acceptable salt, and a process for proparing 5,8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxopyrido(2,3-d)pyrimidines(II), which comprises dehydrogenating 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6.7.8-tetrahydropyrido(2,3-d)pyrimidines (III), or subjecting alkyl 4-(N-substituted ethyl-N-ethyl)amino-2-(1-piperazinyl)-pyrimidine-5-carboxylates(IV) to a Dieckmann reaction, and dehydrogenating the resulting 8-ethyl-2-(1-piperazinyl)-5-oxo-5,6,7,8-tetrahydropyrido(2,3-d)pyrimidines(III). The 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl) pyrido(2,3-d)pyrimidine-6-carboxylic acids (I) and their pharmaceutically acceptable salts are useful as antibacterial agents, and 5 8-dihydro-8-ethyl-2-(1-piperazinyl)-5-oxopyrido(2,3-c)pyrimidines (II) are used as intermediates for producing the 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazinyl) pyrido(2,3-d)pyrimidine-6-carboxylic acids (I). [CA1066701A]
IE00650/74A 1973-04-03 1974-03-25 Method for the preparation of piperazine derivatives IE39102B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3845373A JPS5546400B2 (en) 1973-04-03 1973-04-03
JP5654473A JPS565753B2 (en) 1973-05-21 1973-05-21
JP6446473A JPS565755B2 (en) 1973-06-07 1973-06-07

Publications (2)

Publication Number Publication Date
IE39102L IE39102L (en) 1974-10-03
IE39102B1 true IE39102B1 (en) 1978-08-02

Family

ID=27289838

Family Applications (1)

Application Number Title Priority Date Filing Date
IE00650/74A IE39102B1 (en) 1973-04-03 1974-03-25 Method for the preparation of piperazine derivatives

Country Status (11)

Country Link
AR (2) AR204003A1 (en)
AT (1) AT340931B (en)
CA (1) CA1066701A (en)
CH (1) CH593281A5 (en)
ES (1) ES424851A1 (en)
FI (1) FI56011C (en)
IE (1) IE39102B1 (en)
NL (1) NL186087C (en)
NO (1) NO142221C (en)
PH (2) PH10529A (en)
SE (1) SE416051B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209163B (en) * 1979-12-21 1989-07-10 Unibios S P A Trecate Novara PROCEDURE FOR THE MANUFACTURE OF: 6-ALCOSSICARBONIL-8-ETHYL-5-OXO-5,8 DIIDRO-APERTA PAR. SQUARE 2,3-DCHIUSA PAR. SQUARE-PRIMIDINE 2-REPLACED AND ACID CORRESPONDING BOOKS.
BRPI1015135B1 (en) 2009-06-29 2021-08-03 Incyte Holdings Corporation PI3K-INHIBITING PYRIMIDINONES, COMPOSITION INCLUDING SUCH COMPOUNDS AS WELL AS USES THEREOF
AR079529A1 (en) 2009-12-18 2012-02-01 Incyte Corp ARILO AND HETEROARILO DERIVATIVES REPLACED AND FOUNDED AS INHIBITORS OF THE PI3K
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
WO2012087881A1 (en) 2010-12-20 2012-06-28 Incyte Corporation N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
ES2722524T3 (en) 2011-09-02 2019-08-13 Incyte Holdings Corp Heterocyclamines as pi3k inhibitors
AR090548A1 (en) 2012-04-02 2014-11-19 Incyte Corp BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
MD3831833T2 (en) 2015-02-27 2023-04-30 Incyte Holdings Corp Processes for the preparation of a pi3k inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor

Also Published As

Publication number Publication date
IE39102L (en) 1974-10-03
AR204660A1 (en) 1976-02-20
FI56011C (en) 1979-11-12
NL186087B (en) 1990-04-17
FI56011B (en) 1979-07-31
AR204003A1 (en) 1975-11-12
AT340931B (en) 1978-01-10
PH10984A (en) 1977-10-18
CA1066701A (en) 1979-11-20
NO142221C (en) 1980-07-16
NO142221B (en) 1980-04-08
NL186087C (en) 1990-09-17
NO740349L (en) 1974-10-04
CH593281A5 (en) 1977-11-30
PH10529A (en) 1977-05-30
NL7401509A (en) 1974-10-07
ATA277774A (en) 1977-05-15
ES424851A1 (en) 1976-06-01
SE416051B (en) 1980-11-24

Similar Documents

Publication Publication Date Title
IE39102B1 (en) Method for the preparation of piperazine derivatives
HUP0001560A2 (en) Stable crystal salts of 5-methyl-tetrahydrofolic acid
HUT69407A (en) Process for producing quinolin-4-amine-and 1h-imidazo[4,5-c]quinolin-4-amine derivatives as intermediates
CA2209487A1 (en) Imidazo[4,5-c]quinoline amines
AR241183A1 (en) Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido{1,2,3-de]{1, 4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4- dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carb
IE842947L (en) FURO (3,4-c) PYRIDINES
HUT49889A (en) Process for producing acyl derivatives
CA983030A (en) 2-(substituted pyrrolidino)-8-lower alkyl-5,8-dihydro-5-oxopyrido(2,3-d) pyrimidine-6-carboxylic acid derivatives, and process for the preparation of the same
CA2187409A1 (en) Stable Crystalline Tetrahydrofolic Acid Salts
HUT38344A (en) Process for preparing pyrazolo/3,4-b/pyridine amides
HUT42078A (en) Process for preparing benzoxazine derivatives applicable in the production of herbicides as intermediates
Sloan et al. Enzymatic synthesis of aza-L-tryptophans: The preparation of 5-and 6-aza-L-tryptophan
IE38618B1 (en) Imidazo(1,2-a)imidazoles imidazo(1,2-a)pyrimidines and pyrimido(1,2-a)pyrimidines and methods for their preparation
GB1530413A (en) 5,8-dihydro-5-oxopyrido(2,3-d)pyrimidines
IE35781B1 (en) Process for preparing cephalosporins
GB1272074A (en) Pyridothienopyrimidine derivatives and process for their manufacture
ZA80578B (en) New 2-amino-8-cyclopropyl-5-oxo-5,8-dihydro-pyrido((2,3-d))pyrimidine-6-carboxylic acid compounds,their production and their medicinal use
KR870006059A (en) 6H-isoxazolo [5,4-d] pyrazolo [3,4-b] pyridine and preparation method thereof
Taylor et al. Synthesis of 5, 10-dideaza-5, 6, 7, 8-tetrahydrofolic acid (DDATHF) and analogs
GB1184826A (en) Substituted Aryloxy Hydroxy Amines
AU586707B2 (en) New 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and salts thereof, processes for their preparation and pharmaceutical products containing these
EP0000541A2 (en) 1H-Pyrimido-(4,5-c)-1,2-diazepines, methods for their preparation and compositions containing them; their use as intermediates for heterocyclic transformations.
GB1260857A (en) IMIDAZO-3H-(4,5-b)-PYRIDINE DERIVATIVES
JPS5767584A (en) Thiazolo(3,2-a)pyrimidine derivative, its preparation, and drug containing the same
CA1015753A (en) Process for the preparation of novel pyrido (2,3-d)pyrimidine-2,4(1h,3h)-diones